Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Pneumococcal vaccine Stories

2010-03-04 08:27:47

A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa. The trials, conducted in Malawi and funded by the Wellcome Trust, studied the efficacy of a vaccine against infection with the Streptococcus pneumoniae bacteria. These bacteria are a primary cause of pneumonia and when they invade the blood stream and brain "“ so called invasive pneumococcal disease (IPD)...

2010-02-23 09:10:30

The pneumococcal vaccine for infants and children introduced in 2000 caused a precipitous drop in infections until 2005, when serious illnesses began to rise again, especially infections caused by a strain of the pneumococcal bacteria called 19A, said researchers from Baylor College of Medicine and Texas Children's Hospital in a report in the current issue of the journal Pediatrics. "Of the serotypes (or variants) of Streptococcus pneumoniae (the bacteria that cause pneumococcal disease) now...

2010-02-04 22:24:03

Finds Low Adult Vaccination Rates in U.S. A new report, Adult Immunization: Shots to Save Lives, released today by the Trust for America's Health (TFAH), the Infectious Diseases Society of America (IDSA), and the Robert Wood Johnson Foundation (RWJF) found that more than 30 percent of adults ages 65 and older had not been immunized against pneumonia in 36 states as of 2008.  The U.S. Centers for Disease Control and Prevention (CDC) and other experts recommend that all seniors should be...

2010-02-04 09:00:00

WASHINGTON, Feb. 4 /PRNewswire-USNewswire/ -- A new report, Adult Immunization: Shots to Save Lives, released today by the Trust for America's Health (TFAH), the Infectious Diseases Society of America (IDSA), and the Robert Wood Johnson Foundation (RWJF), found that more than 30 percent of adults ages 65 and older had not been immunized against pneumonia in 36 states as of 2008. The U.S. Centers for Disease Control and Prevention (CDC) and other experts recommend that all seniors should...

2010-02-01 12:10:00

PATH supports FDA advancement of a key step in vaccine development SILVER SPRING, Md., Feb. 1 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration (FDA) today announced a collaboration with PATH to advance development of a vaccine to protect children against diseases caused by Streptococcus pneumoniae (pneumococcus), especially pneumonia. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Worldwide, the bacterium also causes infections of the brain (meningitis),...

9d00b03fd97fc231970b15214189c2a21
2010-01-29 14:49:39

A ten billion dollar pledge has been made by the Bill and Melinda Gates Foundation to aid in the research of new vaccines that will help the world's most underprivileged countries. The Microsoft co-founder and his wife announced the pledge at the World Economic Forum on Friday. "We must make this the decade of vaccines," Bill Gates said in a statement. "Vaccines already save and improve millions of lives in developing countries." Having the tools necessary to modernize the vaccine industry...

2010-01-29 05:00:00

Increased vaccination could save more than 8 million children by 2020; significant funding gaps remain, others must join effort DAVOS, Switzerland, Jan. 29 /PRNewswire-USNewswire/ -- Bill and Melinda Gates announced today that their foundation will commit $10 billion over the next 10 years to help research, develop and deliver vaccines for the world's poorest countries. (Photo: http://www.newscom.com/cgi-bin/prnh/20100129/DC45704) The Gateses said that increased investment in vaccines...

2010-01-06 12:24:35

Rituximab treatment reduced patient response to pneumonia vaccine Researchers from Johns Hopkins University determined that immune responses to the tetanus vaccine were not changed when rituximab in combination with methotrexate (MTX) was compared with MTX alone in patients with rheumatoid arthritis (RA). Responses to a pneumococcal vaccination (Pneumovax® pneumonia vaccine), however, were reduced in RA patients with rituximab. Complete findings of this study are published...

2009-10-19 13:44:40

Use of vaccines can save the lives of millions of children A study published in The Cochrane Review this month concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and x-ray defined pneumonia, was also effective against child deaths. The findings were based on a systematic review of the results of 6 randomized and controlled trials conducted in the US, Africa, Philippines, and Finland. Eighty percent of children were less likely to...

2009-10-07 14:58:46

The introduction of pneumococcal vaccines for treating otitis media in children has not prevented complications from occurring, according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA. In fact, the research suggests that the focus has changed on what complications may arise. The retrospective review studied cases over a five-year period (2003-2008) involving complications in...